Thermolabile Medicines and the Cold Chain: quality that creates safety

Thermolabile drugs are sensitive to temperature and require strict control to maintain their efficacy. Any deviation, however small, can compromise the active ingredient and put the patient's health at risk. This is why the cold chain is one of the most critical points in pharmaceutical logistics.

In this article, we explain the main points about storage, transportation and temperature control to ensure that thermolabile medicines reach their destination safely and with quality.

What are thermolabile drugs?

Thermolabile medicines are products that must be kept under controlled temperatures, usually between 2 °C and 8 °C, to preserve their therapeutic efficacy. They are common in vaccines, insulins, biological products, blood products and other highly complex pharmaceutical compounds.

For this reason, its thermal instability means that transportation, storage and handling require specific care. These drugs cannot tolerate heat spikes or accidental freezing.

Why is the cold chain essential?

A pharmaceutical cold chain is the network of processes and equipment that keeps medicines at the right temperature throughout their logistics cycle, from production to administration to the patient.

When this chain is compromised, the integrity of the medicine can be lost in a way that is invisible to the eye, but serious for the results.

How are sensitive medicines stored?

The storage of thermolabile drugs requires controlled environments and validated infrastructure. Qualified cold rooms are used to maintain the ideal temperature, usually between 2 °C and 8 °C, with alarm systems, redundant sensors and power backup to avoid any oscillation.

But control is not limited to temperature. Factors such as relative humidity, incidence of light and internal ventilation also need to be monitored continuously, as they directly interfere with the physicochemical stability of the inputs.

In addition, the entire structure must comply with the requirements of the Anvisa's RDC 430/2020, This ensures that the environment is able to preserve the integrity of the products throughout the storage period.

The importance of temperature control and traceability

Calibrated and reliable equipment monitors all transportation of thermolabile medication. Ideally, temperature data should be recorded in real time and stored for audits.

In addition complete process traceability - from shipment to destination - is a legal requirement and fundamental to guaranteeing trust and safety at every stage of the chain.

Cold chain in clinical studies: even greater rigor

In the context of clinical studies, cold chain care becomes even more critical.

Many of the drugs used are experimental or highly sensitive. The loss of a single vial could invalidate an arm of the study, affecting schedules and results.

That's why research centers and CROs need to have specialized logistics partners, In addition, it is important to have a team of experts who master not only refrigerated transportation, but also the regulatory requirements surrounding the research sector.

To find out more, read our related article:
👉 Logistics and clinical trials: why does every step matter?

Anvisa rules and RDC 430/2020

Anvisa regulates the cold chain for thermolabile medicines through the RDC 430/2020, which requires:

• Temperature monitoring and control in all operations, in accordance with Article 84
• Storage on thermally qualified media, with backup systems and contingency plans
• Transportation in validated thermal packaging and thermal qualification of routes

These standards therefore ensure that all the players involved (manufacturers, distributors, carriers) maintain uniform technical and legal standards.

What are the risks of a break in the cold chain?

Even a small deviation can have severe effects. So when the cold chain fails:

• The medicine can lose efficiency
• There may be stopping treatment
• The lots can be discarded
• The company may suffer regulatory penalties

The WHO estimates that temperature failures in transportation lead to up to 25% of vaccines being discarded, which highlights the need for strict control.

Active and passive cold chain: understand the difference

Depending on the distance, transportation time and sensitivity of the input, two approaches can be chosen:

• Activeuse of vehicles with automated temperature control - ideal for long distances.
• Passiveuse of thermal boxes with technical ice - suitable for shorter routes.

Therefore, echoosing the right model avoids waste and ensures that the medicine arrives within the technical specifications.

Technological trends in the transportation of thermolabile drugs

Innovation has made pharmaceutical logistics more efficient. Today, solutions such as:

• IoT sensors with geolocation tracking
• Data loggers with remote connectivity
• Blockchain for immutable traceability
• Intelligent software for alert management and compliance

They are being adopted to increase safety, reduce losses and ensure regulatory transparency.

Ensuring efficiency requires more than refrigeration

Keeping medicines at the right temperature is not a detail: it's a requirement for saving lives.

FIC Company is prepared to act with excellence in highly complex pharmaceutical logistics, with a focus on thermolabile drugs and the cold chain.

If you need technical support in the supply, transportation or traceability of sensitive inputs, talk to us.
Contact us